Provided By GlobeNewswire
Last update: Mar 31, 2025
- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -
- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -
- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 -
NYSE:VATE (7/25/2025, 10:29:33 AM)
5.74
+0.04 (+0.7%)
Find more stocks in the Stock Screener